vadimezan: Clinical Trials

2 trials of vadimezan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Terminated 2

Follow vadimezan: new trials by email Literature Review of vadimezan trials Research Report on vadimezan

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer
ASA404, Placebo, docetaxel - Non-Small Cell Lung Cancer
Phase 3TerminatedNovartis Pharmaceuticals9002008-12-012020-12-24
ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer
ASA404, Placebo, carboplatin - Non-Small Cell Lung Cancer
Phase 3TerminatedNovartis Pharmaceuticals12852008-04-012020-12-24

Conditions studied

Carcinoma, Non-Small-Cell Lung (2)

Sponsors

Novartis Pharmaceuticals (2)

Countries

Belgium (2)  ·  Canada (2)  ·  France (2)  ·  Germany (2)  ·  Hungary (2)  ·  Italy (2)  ·  Poland (2)  ·  Spain (2)  ·  United States (2)  ·  Argentina (1)  ·  Australia (1)  ·  Brazil (1)  ·  China (1)  ·  Czechia (1)  ·  Greece (1)